Thymalin

Thymalin is a polypeptide complex originally isolated from the thymus gland, developed by Khavinson and colleagues at the Saint Petersburg Institute of Bioregulation and Gerontology. It belongs to a class of bioregulatory peptides that have been studied extensively in Russian biogerontology research for their effects on immune system restoration and aging. Thymalin is composed of a mixture of short peptides derived from thymic tissue and has been investigated for its ability to restore thymic function and modulate immune competence in aging and immunodeficiency models.

Research has demonstrated that Thymalin influences T-cell maturation and differentiation markers in preclinical cell-culture systems. Studies in aged animal research models have shown shifts in thymic-architecture readouts and immune-cell research markers, including CD4/CD8 ratio profiles and natural-killer-cell activity panels. The peptide has also been investigated for its effects on neuroendocrine regulation, with studies suggesting modulation of melatonin production and circadian cortisol patterns.

Long-term observational studies conducted by Khavinson and colleagues have examined Thymalin's effects in elderly cohorts, reporting improvements in immune markers, cardiovascular parameters, and mortality indices over follow-up periods of up to 12 years. These studies, while primarily conducted within Russian research frameworks, have contributed to the growing field of bioregulatory peptide research in gerontology.